raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:93256

Fragile X-associated tremor/ataxia syndrome

Synonyms: FXTAS syndrome

Type
Malformation syndrome
Group
Disorder
Inheritance
X-linked dominant
Age of onset
Adult
Status
active

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a rare neurodegenerative disorder characterized by adult-onset progressive intention tremor and gait ataxia.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enFragile X-associated tremor/ataxia syndromeFXTAS syndrome
frSyndrome tremblement-ataxie lié à une prémutation de l'X fragileSyndrome FXTAS
deFragiles-X assoziiertes Tremor/Ataxie-SyndromFXTAS
esSíndrome de ataxia/temblor asociado al cromosoma X frágilSíndrome FXTAS
itSindrome dell'X fragile con tremore/atassiaSindrome FXTAS
nlFragiele-X-geassocieerd tremor/ataxie-syndroomFXTAS-syndroom
ptSíndrome de tremor/ataxia associada ao X frágilSíndrome FXTAS
plZespół drżenia/ataksji związany z łamliwym chromosomem XZespół FXTAS
csSyndrom FXTASSyndrom tremoru/ataxie asociovaný s fragilním X
ukСиндром асоційованого з ламкою Х-хромосомою тремору/атаксіїСиндром FXTAS
zh脆性X相关震颤/共济失调综合征FXTAS综合征
trFrajil X-ilişkili tremor / ataksi sendromuFXTAS sendromu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM300623Evalidated
ICD-10G11.2NTBTattributedvalidated
ICD-118A03.1YNTBTindexvalidated
MONDO0010382Evalidated
MeSHC564105Evalidated
UMLSC1839780Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
FMR1Disease-causing germline mutation(s) (gain of function) inAssessedHGNC:3775ENSG00000102081309550Xq27.3fragile X messenger ribonucleoprotein 1
5

Prevalence and incidence

3 records
TypeClassValueAreaQualificationValidationSource
Point prevalence1-9 / 100 000—United StatesClass onlyValidated15000674[PMID]_17166801[PMID]_ [EXPERT]
Lifetime Prevalence1-9 / 100 0006.3 / 100 000United StatesValue and classValidated15000674[PMID]_17166801[PMID]_ [EXPERT]
Point prevalence1-9 / 100 000—EuropeClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

37 annotations · validated 2024-10-09
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0001251Ataxia
HP:0002120Cerebral cortical atrophy
HP:0000726Dementia
HP:0001260Dysarthria
HP:0001310Dysmetria
HP:0002066Gait ataxia
HP:0001288Gait disturbance
HP:0030216Inertia
HP:0002080Intention tremor
HP:0002354Memory impairment
Frequent (79-30%)
HP:0012332Abnormal autonomic nervous system physiology
HP:0000713Agitation
HP:0000739Anxiety
HP:0000722Compulsive behaviors
HP:0000716Depression
HP:0100275Diffuse cerebellar atrophy
HP:0012534Dysesthesia
HP:0001265Hyporeflexia
HP:0000802Impotence
HP:0000737Irritability
HP:0007340Lower limb muscle weakness
HP:0001324Muscle weakness
HP:0009830Peripheral neuropathy
HP:0100515Pollakisuria
HP:0002172Postural instability
HP:0002063Rigidity
HP:0012083Ubiquitin-positive cerebral inclusion bodies
HP:0002839Urinary bladder sphincter dysfunction
Occasional (29-5%)
HP:0002363Abnormal brainstem morphology
HP:0002607Bowel incontinence
HP:0002067Bradykinesia
HP:0002015Dysphagia
HP:0000822Hypertension
HP:0002615Hypotension
HP:0000821Hypothyroidism
HP:0003326Myalgia
HP:0001300Parkinsonism

Run the differential on the 10 obligate / very frequent terms

Annotation source: 20301558[PMID]_24491663[PMID]_18686748[PMID]

7

Sources for this card